Claudia L. Flemming
Kensington, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
CCI52 sensitizes tumors to 6-mercaptopurine and inhibits MYCN-amplified tumor growth.
Journal: Biochemical pharmacology
Published: November 12, 2019
MRP1 modulators synergize with buthionine sulfoximine to exploit collateral sensitivity and selectively kill MRP1-expressing cancer cells.
Journal: Biochemical pharmacology
Published: May 10, 2019
Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma.
Journal: Science translational medicine
Published: May 16, 2018
Suppression of the ATP-binding cassette transporter ABCC4 impairs neuroblastoma tumour growth and sensitises to irinotecan in vivo.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 19, 2017
MYC-Driven Neuroblastomas Are Addicted to a Telomerase-Independent Function of Dyskerin.
Journal: Cancer research
Published: April 01, 2015
ABCA transporter gene expression and poor outcome in epithelial ovarian cancer.
Journal: Journal of the National Cancer Institute
Published: June 25, 2014
High-throughput screening identifies Ceefourin 1 and Ceefourin 2 as highly selective inhibitors of multidrug resistance protein 4 (MRP4).
Journal: Biochemical pharmacology
Published: April 04, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026